| 1 |
DeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C. and Lowy, D. R. 1992. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69, 265-273.
DOI
|
| 2 |
Diez, D., Sanchez-Jimenez, F. and Ranea, J. A. 2011. Evolutionary expansion of the Ras switch regulatory module in eukaryotes. Nucleic Acids Res. 39, 5526-5537.
DOI
|
| 3 |
Dong, P., Nabeshima, K., Nishimura, N., Kawakami, T., Hachisuga, T., Kawarabayashi, T. and Iwasaki, H. 2006. Overexpression and diffuse expression pattern of IQGAP1 at invasion fronts are independent prognostic parameters in ovarian carcinomas. Cancer Lett. 243, 120-127.
DOI
|
| 4 |
Donovan, S., Shannon, K. M. and Bollag, G. 2002. GTPase activating proteins: critical regulators of intracellular signaling. Biochim. Biophys. Acta. 1602, 23-45.
|
| 5 |
Bos, J. L. 1989. Ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
|
| 6 |
Bos, J. L., Rehmann, H. and Wittinghofer, A. 2007. GEFs and GAPs: critical elements in the control of small G proteins. Cell 129, 865-877.
DOI
|
| 7 |
Honda, A. 1., Nogami, M., Yokozeki, T., Yamazaki, M., Nakamura, H., Watanabe, H., Kawamoto, K., Nakayama, K., Morris, A. J., Frohman, M. A. and Kanaho, Y. 1999. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 99, 521-523.
DOI
|
| 8 |
Hamdan, F. F., Gauthier, J., Spiegelman, D., Noreau, A., Yang, Y., Pellerin, S., Dobrzeniecka, S., Cote, M., Perreau-Linck, E., Carmant, L., D'Anjou, G., Fombonne, E., Addington, A. M., Rapoport, J. L., Delisi, L. E., Krebs, M. O., Mouaffak, F., Joober, R., Mottron, L., Drapeau, P., Marineau, C., Lafreniere, R. G., Lacaille, J. C., Rouleau, G. A., Michaud, J. L. and Synapse to Disease Group. 2009. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. New Engl. J. Med. 360, 599-605.
DOI
|
| 9 |
Hedman, A. C., Smith, J. M. and Sacks, D. B. 2015. The biology of IQGAP proteins: beyond the cytoskeleton. EMBO Rep. 16, 427-44.
DOI
|
| 10 |
Henkemeyer, M., Rossi, D. J., Holmyard, D. P., Puri, M. C., Mbamalu, G., Harpal, K., Shih, T. S., Jacks, T. and Pawson, T. 1995. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377, 695-701.
DOI
|
| 11 |
Hordijk, P. L. 2006. Regulation of NADPH oxidases: the role of Rac proteins. Circ. Res. 98, 453-462.
DOI
|
| 12 |
Hu, K. Q. and Settleman, J. 1997. Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation. EMBO J. 16, 473-483.
DOI
|
| 13 |
Ismat, F. A., Xu, J., Lu, M. M. and Epstein, J. A. 2006. The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice. J. Clin. Invest. 116, 2378-2384.
|
| 14 |
Lubeck, B. A., Lapinski, P. E., Oliver, J. A., Ksionda, O., Parada, L. F., Zhu, Y., Maillard, I., Chiang, M., Roose, J. and King, P. D. 2015. Cutting edge: Codeletion of the Ras GTPase-activating proteins (RasGAPs) neurofibromin 1 and p120 RasGAP in T cells results in the development of T cell acute lymphoblastic leukemia. J. Immunol. 195, 31-35.
DOI
|
| 15 |
Lockyer, P. J., Bottomley, J. R., Reynolds, J. S., McNulty, T. J., Venkateswarlu, K., Potter, B. V., Dempsey, C. E. and Cullen, P. J. 1997. Distinct subcellular localisations of the putative inositol 1,3,4,5-tetrakisphosphate receptors  and  result from the PH domain directing plasma membrane targeting. Curr. Biol. 7, 1007-1010.
DOI
|
| 16 |
Lockyer, P. J., Kupzig, S. and Cullen, P. J. 2001. CAPRI regulates }$} "$Ca^{(2+)}$") -dependent inactivation of the Ras-MAPK pathway. Curr. Biol. 11, 981-986.
DOI
|
| 17 |
Lockyer, P. J., Wennstrom, S., Kupzig, S., Venkateswarlu, K., Downward, J. and Cullen, P. J. 1999. Identification of the ras GTPase-activating protein $} "$GAP1(^m)$") as a phosphatidylinositol-3,4,5-trisphosphate-binding protein in vivo. Curr. Biol. 9, 265-268.
DOI
|
| 18 |
Luo, J., Manning, B. D. and Cantley, L. C. 2003. Targeting the PI3K-Akt pathway in human cancer: Rationale and promise. Cancer Cell. 4. 257-262.
DOI
|
| 19 |
Yarwood, S., Bouyoucef-Cherchalli, D., Cullen, P. J. and Kupzig, S. 2006. The GAP1 family of GTPase-activating proteins: spatial and temporal regulators of small GTPase signalling. Biochem. Soc. Trans. 34, 846-850.
DOI
|
| 20 |
Zhang, D. and Aravind, L. 2010. Identification of novel families and classification of the C2 domain superfamily elucidate the origin and evolution of membrane targeting activities in eukaryotes. Gene 469, 18-30.
DOI
|
| 21 |
Prior, I. A., Lewis, P. D. and Mattos, C. 2012. A comprehensive survey of Ras mutations in cancer. Cancer Res. 72, 24572467.
|
| 22 |
Dote, H., Toyooka, S., Tsukuda, K., Yano, M., Ota, T., Murakami, M., Naito, M., Toyota, M., Gazdar, A. F. and Shimizu, N. 2005. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br. J. Cancer 92, 1117-1125.
DOI
|
| 23 |
Dote. H., Toyooka, S., Tsukuda, K., Yano, M., Ouchida, M., Doihara, H., Suzuki, M., Chen, H., Hsieh, J. T., Gazdar, A. F. and Shimizu, N. 2004. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clin. Cancer Res. 10, 2082-2089.
DOI
|
| 24 |
Du, K. and Montminy, M. 1998. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273, 32377-32379.
DOI
|
| 25 |
Perucho, M., Goldfarb, M., Shimizu, K., Lama, C., Fogh, J. and Wigler, M. 1981. Human-tumor-derived cell lines contain common and different transforming genes. Cell 27, 467-476.
DOI
|
| 26 |
Price, S. R., Nightingale, M., Tsai, S. C., Williamson, K. C., Adamik, R., Chen, H. C., Moss, J. and Vaughan, M. 1988. Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA. Proc. Natl. Acad. Sci. USA. 85, 5488-5491.
DOI
|
| 27 |
Pylayeva-Gupta, Y., Grabocka, E. and Bar-Sagi, D. 2011. RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 11, 761-774.
DOI
|
| 28 |
Ramjaun, A. R. and Downward, J. 2007. Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis. Cell Cycle 6, 2902-2905.
DOI
|
| 29 |
Randazzo, P. A., Nie, Z., Miura, K. and Hsu, V. W. 2000. Molecular aspects of the cellular activities of ADP-ribosylation factors. Sci STKE. 2000, re1.
DOI
|
| 30 |
Reiner, D. J. and Lundquist, E. A. 2016. Small GTPases. WormBook. 10, 1895.
|
| 31 |
Ren, J. G., Li, Z. and Sacks, D. B. 2007. IQGAP1 modulates activation of B-Raf. Proc. Natl. Acad. Sci. USA. 104, 10465-10469.
DOI
|
| 32 |
Repasky, G. A., Chenette, E. J. and Der, C. J. 2004. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trend Cell Biol. 14, 639-647.
DOI
|
| 33 |
Van Aelst, L., Barr, M., Marcus, S., Polverino, A. and Wigler, M. 1993. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. USA. 90, 6213-6217.
DOI
|
| 34 |
Tong, J., Hannan, F., Zhu, Y., Bernards, A. and Zhong, Y. 2002. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat. Neurosci. 5, 95-96.
DOI
|
| 35 |
Touchot, N., Chardin, P. and Tavitian, A. 1987. Four additional members of the ras gene superfamily isolated by an oligonucleotide strategy: molecular cloning of YPT-related cDNAs from a rat brain library. Proc. Natl. Acad. Sci. USA. 84, 8210-8214.
DOI
|
| 36 |
Tsuchida, N., Ryder, T. and Ohtsubo, E. 1982. Nucleotide sequence of the oncogene encoding the p21 transforming protein of Kirsten murine. Science 217, 937-939.
DOI
|
| 37 |
van der Geer, P., Henkemeyer, M., Jacks, T. and Pawson, T. 1997. Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap. Mol. Cell. Biol. 17, 1840-1847.
DOI
|
| 38 |
Vanhaesebroeck, B. and Alessi, D. R. 2000. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346, 561-576.
|
| 39 |
Vazquez, L. E., Chen, H. J., Sokolova, I., Knuesel, I. and Kennedy, M. B. 2004. SynGAP regulates spine formation. J. Neurosci. 24, 8862-8872.
DOI
|
| 40 |
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., White, R. and O'Connell, P. 1990. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62, 187-192.
DOI
|
| 41 |
Vogel, U. S., Dixon, R. A., Schaber, M. D., Dihl, R. E., Marshall, M. S., Scolnick, E. M., Sigal, I. S. and Gibbs, J. B. 1988. Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 335, 90-93.
DOI
|
| 42 |
Zhang, J., Guo, J., Dzhagalov, I. and He, Y. W. 2005. An essential function for the calcium-promoted Ras inactivator in Fc gamma receptor-mediated phagocytosis. Nat. Immunol. 6, 911-919.
DOI
|
| 43 |
Zhang, D. and Aravind, L. 2012. Novel transglutaminase-like peptidase and C2 domains elucidate the structure, biogenesis and evolution of the ciliary compartment. Cell Cycle 11, 3861-3875.
DOI
|
| 44 |
Zhang, H., He, Y., Dai, S., Xu, Z., Luo, Y., Wan, T., Luo, D., Jones, D., Tang, S., Chen, H., Sessa, W. C. and Min, W. 2008. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. J. Clin. Invest. 118, 3904-3916.
DOI
|
| 45 |
Zhang, H., Zhang, R., Luo, Y., D'Alessio, A., Pober, J. S. and Min, W. 2004. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. J. Biol. Chem. 279, 44955-44965.
DOI
|
| 46 |
Zhang, R., He, X., Liu, W., Lu, M., Hsieh, J. T. and Min, W. 2003. AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating dissociation of ASK1 from its inhibitor 14-3-3. J. Clin. Invest. 111, 1933-1943.
DOI
|
| 47 |
Zhang, X. F., Settleman, J., Kyriakis, J. M., Takeuchi-Suzuki, E., Elledge, S. J., Marshall, M. S., Bruder, J. T., Rapp, U. R. and Avruch, J. 1993. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 364, 308-318.
DOI
|
| 48 |
Ekman, S., Thuresson, E. R., Heldin, C. H. and Ronnstrand, L. 1999. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding. Oncogene 18, 2481-248.
DOI
|
| 49 |
Duggan, Zheng, S. L., Knowlton, M., Benitez, D., Dimitrov, L., Wiklund, F., Robbins, C., Isaacs, S. D., Cheng, Y., Li, G., Sun, J, Chang, B. L., Marovich, L., Wiley, K. E., Stattin, P., Adami, H. O., Gielzak, M., Yan, G., Sauvageot, J., Liu, W., Kim, J. W., Bleeker, E. R., Meyers, D. A., Trock, B. J., Partin, A. W., Walsh, P. C., Isaacs, W. B., Gronberg, H., Xu, J. and Carpten, J. D. 2007. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J. Nat. Cancer Inst. 99, 1836-1844.
DOI
|
| 50 |
Eerola, I., Boon, L. M., Mulliken, J. B., Burrows, P. E., Dompmartin, A., Watanabe, S., Vanwijck, R. and Vikkula, M. 2003. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am. J. Hum. Genet. 73, 1240-1249.
DOI
|
| 51 |
Engelman, J. A. 2009. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 9, 550-562.
DOI
|
| 52 |
Brems, H., Park, C., Maertens, O., Pemov, A., Messiaen, L., Upadhyaya, M., Claes, K., Beert, E., Peeters, K., Mautner, V., Sloan, J. L., Yao, L., Lee, C. C., Sciot, R., De Smet, L., Legius, E. and Stewart, D. R. 2009. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association. Cancer Res. 69, 7393-7401.
DOI
|
| 53 |
Bourguignon, L. Y., Gilad, E., Rothman, K. and Peyrollier, K. 2005. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. J. Biol. Chem. 280, 11961-11972.
DOI
|
| 54 |
Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F. and Copeland, N. G. 1994. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8, 1019-1029.
DOI
|
| 55 |
Brems, H., Chmara, M., Sahbatou, M., Denayer, E., Taniguchi, K., Kato, R., Somers, R., Messiaen, L., De Schepper, S., Fryns, J. P., Cools, J., Marynen, P., Thomas, G., Yoshimura, A. and Legius, E. 2007. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat. Genet. 39, 1120-1126.
DOI
|
| 56 |
Brill, S., Li, S., Lyman, C. W., Church, D. M., Wasmuth, J. J., Weissbach, L., Bernards, A. and Snijders, A. J. 1996. The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol. Cell. Biol. 16, 4869-4878.
DOI
|
| 57 |
Bryant, S. S., Briggs, S., Smithgall, T. E., Martin, G. A., McCormick, F., Chang, J. H., Parsons, S. J. and Jove, R. 1995. Two SH2 domains of p120 Ras GTPase-activating protein bind synergistically to tyrosine phosphorylated p190 Rho GTPase-activating protein. J. Biol. Chem. 270, 17947-17952.
DOI
|
| 58 |
Erickson, J. W., Cerione, R. A. and Hart, M. J. 1997. Identification of an actin cytoskeletal complex that includes IQGAP and the Cdc42 GTPase. J. Biol. Chem. 26, 24443-24447.
|
| 59 |
Fantl, W. J., Escobedo, J. A., Martin, G. A., Turck, C. W., del Rosario, M., McCormick, F. and Williams, L. T. 1992. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69, 413-42.3
DOI
|
| 60 |
Feng, M., Bao, Y., Li, J., Gong, M., Wang, J., Marzese, D. M., Donovan, N., Tan, E. Y., Hoon, D. S. and Yu, Q. 2014. RASAL2 activates Rac1 to promote triple-negative breast cancer progression. J. Clin. Invest. 124, 5291-5304.
DOI
|
| 61 |
Jeong, J. H., Wang, Z., Guimaraes, A. S., Ouyang, X., Figueiredo, J. L., Ding, Z., Jiang, S., Guney, I., Kang, G. H., Shin, E., Hahn, W. C., Loda, M. F., Abate-Shen, C., Weissleder, R. and Chin, L. 2008. BRAF activation initiates but does not maintain invasive prostate adenocarcinoma. PLoS One 3, e3949.
DOI
|
| 62 |
Iwashita, S., Kobayashi, M., Kubo, Y., Hinohara, Y., Sezaki, M., Nakamura, K., Suzuki-Migishima, R., Yokoyama, M., Sato, S., Fukuda, M., Ohba, M., Kato, C., Adachi, E. and Song, S. Y. 2007. Versatile roles of R-Ras GAP in neurite formation of PC12 cells and embryonic vascular development. J. Biol. Chem. 282, 3413-3417.
|
| 63 |
Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A. and Weinberg, R. A. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat. Genet. 7, 353-361.
DOI
|
| 64 |
Jaffee, E. M., Hruban, R. H., Canto, M., Kern, S. E. 2002. Focus on pancreas cancer. Cancer Cell. 2, 25-28.
DOI
|
| 65 |
Jin, H., Wang, X., Ying, J., Wong, A. H., Cui, Y., Srivastava, G., Shen, Z. Y., Li, E. M., Zhang, Q., Jin, J., Kupzig, S., Chan, A. T., Cullen, P. J. and Tao, Q. 2007. Epigenetic silencing of a -regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proc. Natl. Acad. Sci. USA. 104, 12353-12348.
DOI
|
| 66 |
Jin, S. H., Akiyama, Y., Fukamachi, H., Yanagihara, K., Akashi, T. and Yuasa, Y. 2008. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Int. J. Cancer 122, 1040-1046.
|
| 67 |
Johannessen, C. M., Reczek, E. E., James, M. F., Brems, H., Legius, E. and Cichowski, K. 2005. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc. Natl. Acad. Sci. USA. 102, 8573-8578.
DOI
|
| 68 |
Maertens, O., Brems, H., Vandesompele, J., De Raedt, T., Heyns, I., Rosenbaum, T., De Schepper, S., De Paepe, A., Mortier, G., Janssens, S., Speleman, F., Legius, E. and Messiaen, L. 2006. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum. Mutat. 27, 1030-1040.
DOI
|
| 69 |
Macmurdo, C. F., Wooderchak-Donahue, W., Bayrak-Toydemir, P., Le, J. Wallenstein, M. B., Milla, C., Teng, J. M., Bernstein, J. A. and Stevenson, D. A. 2016. RASA1 somatic mutation and variable expressivity in capillary malformation/ arteriovenous malformation (CM/AVM) syndrome. Am. J. Med. Genet. 170, 1450-1454.
DOI
|
| 70 |
Maekawa, M., Li, S., Iwamatsu, A., Morishita, T., Yokota, K., Imai, Y., Kohsaka, S., Nakamura, S. and Hattori, S. 1994. A novel mammalian Ras GTPase-activating protein which has phospholipid-binding and Btk homology regions. Mol. Cell. Biol. 14, 6879-6885.
DOI
|
| 71 |
Malik, S. N., Brattain, M., Ghosh, P. M., Troyer, D. A., Prihoda, T., Bedolla, R. and Kreisberg, J. I. 2002. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin. Cancer Res. 8, 1168-1171.
|
| 72 |
Manning, B. D. and Cantley, L. C. 2007. AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274.
DOI
|
| 73 |
Marchuk, D. A., Saulino, A. M., Tavakkot, R., Swaroop, M., Wallace, M. R., Andersen, L. B., Mitchell, A. L., Gutmann, D. H., Boguski, M. and Collins, F. S. 1991. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11, 931-940.
DOI
|
| 74 |
Margolis, B., Li, N., Koch, A., Mohammadi, M., Hurwitz, D. R., Zilberstein, A., Ullrich, A., Pawson, T. and Schlessinger, J. 1990. The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma. EMBO J. 9, 4375-4380.
DOI
|
| 75 |
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L. Brownstein, B. H. and Collins, F. S. 1990. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249, 181-186.
DOI
|
| 76 |
Revencu, N., Boon, L. M., Mulliken, J. B., Enjolras, O., Cordisco, M. R., Burrows, P. E., Clapuyt, P., Hammer, F., Dubois, J., Baselga, E., Brancati, F., Carder, R., Quintal, J. M., Dallapiccola, B., Fischer, G., Frieden, I. J., Garzon, M., Harper, J., Johnson-Patel, J., Labreze, C., Martorell, L., Paltiel, H. J., Pohl, A., Prendiville, J., Quere, I., Siegel, D. H., Valente, E. M., Van Hagen, A., Van Hest, L., Vaux, K. K., Vicente, A., Weibel, L., Chitayat, D. and Vikkula, M. 2008. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum. Mutat. 29, 959-996.
DOI
|
| 77 |
Revencu, N., Boon, L. M., Mendola, A., Cordisco, M. R., Dubois, J., Clapuyt, P., Hammer, F., Amor, D. J., Irvine, A. D., Baselga, E., Dompmartin, A., Syed, S., Martin-Santiago, A., Ades, L., Collins, F., Smith, J., Sandaradura, S., Barrio, V. R., Burrows, P. E., Blei, F., Cozzolino, M., Brunetti-Pierri, N., Vicente, A., Abramowicz, M., Desir, J., Vilain, C., Chung, W. K., Wilson, A., Gardiner, C. A., Dwight, Y., Lord, D. J., Fishman, L., Cytrynbaum, C., Chamlin, S., Ghali, F., Gilaberte, Y., Joss, S., Boente Mdel, C., Leaute- Labreze, C., Delrue, M. A., Bayliss, S., Martorell, L., Gonzalez-Ensenat, M. A., Mazereeuw-Hautier, J., O'Donnell, B., Bessis, D., Pyeritz, R. E., Salhi, A., Tan, O. T., Wargon, O., Mulliken, J. B. and Vikkul, M. 2013. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation. Hum. Mut. 34, 1632-1641.
DOI
|
| 78 |
Vojtek, A. B., Hollenberg, S. M. and Cooper, J. A. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74, 205-214.
DOI
|
| 79 |
Walker, J. A., Gouzi, J. Y., Long, J. B., Huang, S., Maher, R. C., Xia, H., Khalil, K., Ray, A., Van Vactor, D., Bernards, R. and Bernards, A. 2013. Genetic and functional studies implicate synaptic overgrowth and ring gland cAMP/PKA signaling defects in the Drosophila melanogaster neurofibromatosis-1 growth deficiency. PLoS Genet. 9, e1003958.
DOI
|
| 80 |
Walker, S. A., Kupzig, S., Bouyoucef, D., Davies, L. C., Tsuboi, T., Bivona, T. G., Cozier, G. E., Lockyer, P. J., Buckler, A., Rutter, G. A., Allen, M. J., Philips, M. R. and Cullen, P. J. 2004. Identification of a Ras GTPase-activating protein regulated by receptor-mediated  oscillations. EMBO J. 23, 1749-1760.
DOI
|
| 81 |
Wan, Y. J., Yang, Y., Leng, Q. L., Lan, B., Jia, H. Y., Liu, Y. H., Zhang, C. Z. and Cao, Y. 2014. Vav1 increases Bcl-2 expression by selective activation of Rac2-Akt in leukemia T cells. Cell. Signal. 26, 2202-2209.
DOI
|
| 82 |
Wang, S., Watanabe, T., Noritake, J., Fukata, M., Yoshimura, T., Itoh, N., Harada, T., Nakagawa, M., Matsuura, Y., Arimura, N. and Kaibuchi, K. 2007. IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J. Cell Sci. 120, 567-577.
DOI
|
| 83 |
Wang, X. X., Li, X. Z., Zhai, L. Q., Liu, Z. R., Chen, X. J. and Pei, Y. 2013. Overexpression of IQGAP1 in human pancreatic cancer. Hepatobiliary Pancreat. Dis. Int. 12, 540-545.
DOI
|
| 84 |
Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
DOI
|
| 85 |
Burridge, K. and Wennerberg, K. 2004. Rho and Rac take center stage. Cell 116, 167-179.
DOI
|
| 86 |
Burrows, N., Telfer, B., Brabant, G. and Williams, K. J. 2013. Inhibiting the phosphatidylinositide 3-kinase pathway blocks radiation-induced metastasis associated with Rho-GTPase and Hypoxia-inducible factor-1 activity. Radiother. Oncol. 108, 548-553.
DOI
|
| 87 |
Calvisi, D. F., Ladu, S., Conner, E. A., Seo, D., Hsieh, J. T., Factor, V. M. and Thorgeirsson, S. S. 2011, Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J. Hepatol. 54, 311-319.
DOI
|
| 88 |
Carazo-Salas, R. E., Gruss, O. J., Mattaj, I. W. and Karsenti, E. 2001. Ran-GTP coordinates regulation of microtubule nucleation and dynamics during mitotic-spindle assembly. Nat. Cell Biol. 3, 228-234.
DOI
|
| 89 |
Rodriguez-Viciana, P., Warne, P. H., Vanhaesebroeck, B., Waterfield, M. D. and Downward, J. 1996. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15, 2442-2451.
DOI
|
| 90 |
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D. and Downward, J. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
DOI
|
| 91 |
Buday, L. and Downward, J. 2008. Many faces of Ras activation. Biochim. Biophys. Acta. 1786, 178-187.
|
| 92 |
Carlisle, H. J., Manzerra, P., Marcora, E. and Kennedy, M. B. 2008. SynGAP regulates steady-state and activity-dependent phosphorylation of cofilin. J. Neurosci. 28, 13673-13683.
DOI
|
| 93 |
Castellano, E. and Downward, J. 2011. RAS interaction with PI3K: More than just another effector pathway. Genes Cancer 2, 261-274.
DOI
|
| 94 |
Cawthon, R. M., Weiss, R., Xu, G. F., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P. and White, R. 1990. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62, 193-201.
DOI
|
| 95 |
Chang, J. S. 2003. Pleckstrin homology domain. Biochem. Mol. Biol. News. 23, 209-216
|
| 96 |
Karnoub, A. E. and Weinberg, R. A. 2008. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell. Biol. 9, 517-531.
DOI
|
| 97 |
Jones, D. H., Morris, J. B., Morgan, C. P., Kondo, H., Irvine, R. F. and Cockcroft, S. 2000. Type I phosphatidylinositol 4-phosphate 5-kinase directly interacts with ADP-ribosylation factor 1 and is responsible for phosphatidylinositol 4,5-bisphosphate synthesis in the golgi compartment. J. Biol. Chem. 275, 13962-13866.
DOI
|
| 98 |
Jouhilahti, E. M., Peltonen, S., Heape, A. M. and Peltonen, J. 2011. The pathoetiology of neurofibromatosis 1. Am. J. Pathol. 178, 1932-1939.
DOI
|
| 99 |
Kahn, R. A. and Gilman, A. G.1984. Purification of a protein cofactor required for ADP-ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera toxin. J. Biol. Chem. 259, 6228-6234.
|
| 100 |
Kazlauskas, A., Ellis, C., Pawson, T. and Cooper, J. A. 1990. Binding of GAP to activated PDGF receptors. Science 247, 1578-1581.
DOI
|
| 101 |
Kim, J. H., Lee, H. K., Takamiya, K. and Huganir, R. L. 2003. The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity. J. Neurosci. 23, 1119-1124.
DOI
|
| 102 |
Kim, J. H., Liao, D., Lau, L. F. and Huganir, R. L. 1998. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20, 683-691.
DOI
|
| 103 |
Knuesel, I., Elliott, A., Chen, H. J., Mansuy, I. M. and Kennedy, M. B. 2005. A role for synGAP in regulating neuronal apoptosis. Eur. J. Neurosci. 21, 611-621.
DOI
|
| 104 |
McLaughlin, S. K., Olsen, S. N., Dake, B., De Raedt, T., Lim, E., Bronson, R. T., Beroukhim, R., Polyak, K., Brown, M., Kuperwasser, C. and Cichowski, K. 2013. The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. Cancer Cell 24, 365-378.
DOI
|
| 105 |
Martin, G. A., Viskochil, D., Bollag, G., McCabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O'Connell, P., Cawthon, R. M., Innis, M. A. and McCormick, F. 1990. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63, 843-849.
DOI
|
| 106 |
McClatchey, A. I. 2007. Neurofibromatosis. Annu. Rev. Pathol. 2, 191-216.
DOI
|
| 107 |
McDonald, K. L., O'Sullivan, M. G., Parkinson, J. F., Shaw, J. M., Payne, C. A., Brewer, J. M., Young, L., Reader, D. J., Wheeler, H. T., Cook, R. J., Biggs, M. T., Little, N. S., Teo, C., Stone, G. and Robinson, B. G. 2007. IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients. J. Neuropathol. Exp. Neurol. 66, 205-417.
|
| 108 |
Messiaen, L., Yao, S., Brems, H., Callens, T., Sathienkijkanchai, A., Denayer, E., Spencer, E., Arn, P., Babovic-Vuksanovic, D., Bay, C., Bobele, G., Cohen, B. H., Escobar, L., Eunpu, D., Grebe, T., Greenstein, R., Hachen, R., Irons, M., Kronn, D., Lemire, E., Leppig, K., Lim, C., McDonald, M., Narayanan, V., Pearn, A., Pedersen, R., Powell, B., Shapiro, L. R., Skidmore, D., Tegay, D., Thiese, H., Zackai, E. H., Vijzelaar, R., Taniguchi, K., Ayada, T., Okamoto, F., Yoshimura, A., Parret, A., Korf, B. and Legius, E. 2009. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA. 302, 2111-2118.
DOI
|
| 109 |
Roy, M., Li, Z. and Sacks, D. B. 2004. IQGAP1 binds ERK2 and modulates its activity. J. Biol. Chem. 279, 17329-17337.
DOI
|
| 110 |
Roof, R. W., Haskell, M. D., Dukes, B. D., Sherman, N., Kinter, M. and Parsons, S. J 1998. Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAPp120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation. Mol. Cell. Biol. 18, 7052-7063.
DOI
|
| 111 |
Roy, M., Li, Z. and Sacks, D. B. 2005. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling. Mol. Cell. Biol. 25, 7940-7952.
DOI
|
| 112 |
Rumbaugh, G., Adams, J. P., Kim, J. H. and Huganir, R. L. 2006. SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc. Natl. Acad. Sci. USA. 103, 4344-4351.
DOI
|
| 113 |
Sahai, E. and Marshall, C. J. 2002. RHO-GTPases and cancer. Nat. Rev. Cancer 2, 133-142.
DOI
|
| 114 |
Warne, P. H., Viciana, P. R. and Downward, J. 1993. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364, 352-353.
DOI
|
| 115 |
Kolfschoten, I. G., van Leeuwen, B., Berns, K., Mullenders, J., Beijersbergen, R. L., Bernards, R., Voorhoeve, P. M. and Agami, R. 2005. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity. Cell 121, 849-858.
DOI
|
| 116 |
Wang, Y., Boguski, M., Riggs, M., Rodgers, L. and Wigler, M. 1991. sar1, a gene from Schizosaccharomyces pombe encoding a protein that regulates ras1. Cell Regul. 2, 453-465.
DOI
|
| 117 |
Wang, Z., Tseng, C. P., Pong, R. C., Chen, H., McConnell, J. D., Navone, N. and Hsieh, J. T. 2002. The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2. J. Biol. Chem. 277, 12622-12631.
DOI
|
| 118 |
Weeks, A., Okolowsky, N., Golbourn, B., Ivanchuk, S., Smith, C. and Rutka, J. T. 2012. ECT2 and RASAL2 mediate mesenchymal-amoeboid transition in human astrocytoma cells. Am. J. Pathol. 181, 662-674.
DOI
|
| 119 |
Weis, K. 2003. Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 112, 441-451.
DOI
|
| 120 |
Weissbach, L., Settleman, J., Kalady, M. F., Snijders, A. J., Murthy, A. E., Yan, Y. X. and Bernards, A. 1994. Identification of a human rasGAP-related protein containing calmodulin-binding motifs. J. Biol. Chem. 269, 20517-20521.
|
| 121 |
Welti, S., Fraterman, S., D'Angelo, I., Wilm, M. and Scheffzek, K. 2007. The sec14 homology module of neurofibromin binds cellular glycerophospholipids: mass spectrometry and structure of a lipid complex. J. Mol. Biol. 366, 551-562.
DOI
|
| 122 |
Komiyama, N. H., Watabe, A. M., Carlisle, H. J., Porter, K., Charlesworth, P., Monti, J., Strathdee, D. J., O'Carroll, C. M, Martin, S. J., Morris, R. G., O'Dell, T. J. and Grant, S. G. 2002. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J. Neurosci. 22, 9721-9732.
DOI
|
| 123 |
Min, J., Zaslavsky, A., Fedele, G., McLaughlin, S. K., Reczek, E. E., De Raedt, T., Guney, I., Strochlic, D. E., MacConaill, L. E., Beroukhim, R., Bronson, R. T., Ryeom, S. Hahn, W. C., Loda, M. and Cichowski, K. 2010. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor- . Nat. Med. 16, 286-294.
DOI
|
| 124 |
Saito, S., Kawamura, T., Higuchi, M., Kobayashi, T., Yoshita-Takahashi, M., Yamazaki, M., Abe, M., Sakimura, M., Kanda, Y., Kawamura, H., Jiang, S., Naito, M., Yoshizaki, T., Takahashi, M. and Fujii, M. 2015. RASAL3, a novel hematopoietic RasGAP protein, regulates the number and functions of NKT cells. Eur. J. Immunol. 45, 1512-1523.
DOI
|
| 125 |
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmuller, L., Lautwein, A., Schmitz, F. and Wittinghofer, A. 1997. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277, 333-338.
DOI
|
| 126 |
Schmidt, V. A., Chiariello, C. S., Capilla, E., Miller, F. and Bahou, W. F. 2008. Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. Mol. Cell. Biol. 28, 1489-1502.
DOI
|
| 127 |
Segev, N. 2001. Ypt and Rab GTPases: insight into functions through novel interactions. Curr. Opin. Cell Biol. 13, 500-511.
DOI
|
| 128 |
Wennerberg, K. and Der, C. J. 2004. Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci. 117, 1301-1312.
DOI
|
| 129 |
Wennerberg, K., Rossman, K. L. and Der, C. J. 2005. The Ras superfamily at a glance. J. Cell Sci. 118, 843-846.
DOI
|
| 130 |
Abramowicz, A. and Gos, M. 2014. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease. Dev. Period. Med. 18, 297-306.
|
| 131 |
Komiyama, N. H., Watabe, A. M., Carlisle, H. J., Porter, K., Charlesworth, P., Monti, J., Strathdee, D. J., O'Carroll, C. M., Martin, S. J., Morris, R. G., O'Dell, T. J. and Grant, S. G. 2004. SynGAP regulates spine formation. J. Neurosci. 24, 8862-8872.
DOI
|
| 132 |
Krapivinsky, G., Medina, I., Krapivinsky, L., Gapon, S. and Clapham, D. E. 2004. SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron 43, 563-574.
DOI
|
| 133 |
Krontiris, T.G. and Cooper, G. M. 1981. Transforming activity of human tumor DNAs. Proc. Natl. Acad. Sci. USA. 78, 1181-1184.
DOI
|
| 134 |
Kulkami, S. V., Gish, G., van der Geer, P., Henkemeyer, M. and Pawson, T. 2000. Role of p120 Ras-Gap in directed movement. J. Cell Biol. 149, 457-470.
DOI
|
| 135 |
Kuroda, S., Fukata, M., Kobayashi, K., Nakafuku, M., Nomura, N., Iwamatsu, A. and Kaibuchi, K. 1996. Identification of IQGAP as a putative target for the small GTPases, Cdc42 and Rac1. J. Biol. Chem. 271, 23363-23367.
DOI
|
| 136 |
Mitsuuchi, Y. and Testa, J. R. 2002. Cytogenetics and molecular genetics of lung cancer. Am. J. Med. Genet. 115, 183-188.
DOI
|
| 137 |
Serra, E., Rosenbaum, T., Winner, U., Aledo, R., Ars, E., Estivill, X., Lenard, H. G. and Lazaro, C. 2000. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum. Mol. Genet. 9, 3055-3064.
DOI
|
| 138 |
Sewell, J. L. and Kahn, R. A. 1988. Sequences of the bovine and yeast ADP-ribosylation factor and comparison to other GTP-binding proteins. Proc. Natl. Acad. Sci. USA. 85, 4620-4624.
DOI
|
| 139 |
Shen, M. M. and Abate-Shen, C. 2007. Pten inactivation and the emergence of androgen-independent prostate cancer. Cancer Res. 67, 6535-6538.
DOI
|
| 140 |
Kumar, D., Hassan, M. K., Pattnaik, N., Mohapatra, N. and Dixit, M. 2017. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers. PLoS One 12, e0186977.
DOI
|
| 141 |
Lapinski, P. E., Bauler, T. J., Brown, E. J., Hughes, E. D., Saunders, T. L. and King, P. D. 2007. Generation of mice with a conditional allele of the p120 Ras GTPase-activating protein. Genesis 45, 762-767.
DOI
|
| 142 |
Westbrook, T. F., Martin, E. S., Schlabach, M. R., Leng, Y., Liang, A. C., Feng, B., Zhao, J. J., Roberts, T. M., Mandel, G., Hannon, G. J., Depinho, R. A., Chin, L. and Elledge, S. J. 2005. A genetic screen for candidate tumor suppressors identifies REST. Cell 121, 837-848.
DOI
|
| 143 |
White C. D., Khurana, H., Gnatenko, D. V., Li, Z., Odze, R. D., Sacks, D. B. and Schmidt, V. A. 2010. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. BMC Gastroenterol. 10, 125.
DOI
|
| 144 |
White, C. D., Brown, M. D. and Sacks, D. B. 2009. IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett. 583, 1817-1824.
DOI
|
| 145 |
White, C. D., Erdemir, H. H. and Sacks, D. B. 2012. IQGAP1 and its binding proteins control diverse biological functions. Cell. Signal. 24, 826-834.
DOI
|
| 146 |
Wilde, A. 1., Lizarraga, S. B., Zhang, L., Wiese, C., Gliksman, N. R., Walczak, C. E. and Zheng, Y. 2001. Ran stimulates spindle assembly by altering microtubule dynamics and the balance of motor activities. Nat. Cell Biol. 3, 221-227.
DOI
|
| 147 |
Cherfils, J. and Zeghouf, M. 2013. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol. Rev. 93, 269-309.
DOI
|
| 148 |
Chen, H., Pong, R. C., Wang, Z. and Hsieh, J. T. 2002. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization. Genomics 79, 573-581.
DOI
|
| 149 |
Chen, H., Toyooka, S., Gazdar, A. F. and Hsieh, J. T. 2003. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. J. Biol. Chem. 278, 3121-313.0
DOI
|
| 150 |
Chen, Y. L., Huang, W. C., Yao, H. L., Chen, P. M., Lin, P. Y., Feng, F. Y. and Chu, P. Y. 2017. Down-regulation of RASA1 Is associated with poor prognosis in human hepatocellular carcinoma. Anticancer Res. 37. 781-785.
DOI
|
| 151 |
Cockcroft, S., Way, G., O'Luanaiqh, N., Sarri, E. and Fensome, A. 2002. Signalling role for ARF and phospholipase D in mast cell exocytosis stimulated by crosslinking of the high affinity FcepsilonR1 receptor. Mol. Immunol. 38, 1277-1282.
DOI
|
| 152 |
Nieborowska-Skorska, M., Kopinski, P. K., Ray, R., Hoser, G., Ngaba, D., Flis, S., Cramer, K., Reddy, M. M., Koptyra, M., Penserga, T., Glodkowska-Mrowka, E., Bolton, E., Holyoake, T. L., Eaves, C. J., Cerny-Reiterer, S., Valent, P., Hochhaus, A., Hughes, T. P., van der Kuip, H., Sattler, M., Wiktor-Jedrzejczak, W., Richardson, C., Dorrance, A., Stoklosa, T., Williams, D. A. and Skorski, T. 2012. Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood 119, 4253-4263.
DOI
|
| 153 |
Agazie, Y. M., Movilla, N., Ischenko, I. and Hayman, M. J. 2003. The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3. Oncogene 22, 6909-6918.
DOI
|
| 154 |
Muhia, M., Feldon, J., Knuesel, I. and Yee, B. K. 2009. Appetitively motivated instrumental learning in SynGAP heterozygous knockout mice. Behav. Neurosci. 123, 1114-1128.
DOI
|
| 155 |
Muhia, M., Yee, B. K., Feldon, J., Markopoulos, F. and Knuesel, I. 2010. Disruption of hippocampus-regulated behavioural and cognitive processes by heterozygous constitutive deletion of SynGAP. Eur. J. Neurosci. 31, 529-543.
DOI
|
| 156 |
Muro, R., Nitta, T., Okada, T., Ideta, H., Tsubata, T. and Suzuki, H. 2015. The ras GTPase activating protein Rasal3 supports survival of naive T cells. PLoS One 10, e0119898.
DOI
|
| 157 |
Nabeshima, K., Shimao, Y., Inoue, T. and Koono, M. 2002. Immunohistochemical analysis of IQGAP1 expression in human colorectal carcinomas: its overexpression in carcinomas and association with invasion fronts. Cancer Lett. 176, 101-109.
DOI
|
| 158 |
Nojima, H., Adachi, M., Matsui, T., Okawa, K., Tsukita, S. and Tsukita, S. 2008. IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. Nat. Cell Biol. 10, 971-978.
DOI
|
| 159 |
Shin, Y., Kim, Y. W., Kim, H., Shin, N., Kim, T. S., Kwon, T. K., Choi, J. H. and Chang, J. S. 2018. RASAL3 preferentially stimulates GTP hydrolysis of the Rho family small GTPase Rac2. Biomed. Rep. 9, 241-246.
|
| 160 |
Shih, C., Padhy, L. C., Murray, M. and Weinberg, R. A. 1981. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290, 261-264.
DOI
|
| 161 |
Shinohara, N., Ogiso, Y., Tanaka, M., Sazawa, A., Harabayashi, T. and Koyanagi, T. 1997. The significance of Ras guanine nucleotide exchange factor, son of sevenless protein, in renal cell carcinoma cell lines. J. Urol. 158, 908-911.
DOI
|
| 162 |
Spurlock, G., Bennett, E., Chuzhanova, N., Thomas, N., Jim, H. P., Side, L., Davies, S., Haan, E., Kerr, B., Huson, S. M. and Upadhyaya, M. 2009 SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype. J. Med. Genet. 46, 431-437.
DOI
|
| 163 |
Stenmark, H. and Olkkonen, V. M. 2001. Rab GTPase family. Genome Biol. 2, reviews 3007.1-3007.7.
|
| 164 |
Chang, L. and Karin, M. 2001. Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
DOI
|
| 165 |
Wong-Staal, F., Dalla-Favera, R., Gelmann, E. P., Manzari, V., Szala, S., Josephs, S. F. and Gallo, R. C. 1981. The v-sis transforming gene of simian sarcoma virus is a new onc gene of primate origin. Nature 294, 273-275.
DOI
|
| 166 |
Xie, D., Gore, C., Liu, J., Pong, R. C., Mason, R., Hao, G., Long, M., Kabbani, W., Yu, L., Zhang, H., Chen, H., Sun, X., Boothman, D. A., Min, W. and Hsieh, J. T. 2010. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc. Natl. Acad. Sci. USA. 107, 2485-2490.
DOI
|
| 167 |
Xie, D., Gore, C., Zhou, J., Pong, R. C., Zhang, H., Yu, L., Vessella, R. L., Min, W. and Hsieh, J. T. 2009. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc. Natl. Acad. Sci. USA. 106, 19878-19883.
DOI
|
| 168 |
Colicelli, J. 2004. Human RAS superfamily proteins and related GTPases. Sci. STKE. 250, RE13.
|
| 169 |
Cooper, J. A. and Kashishian, A. 1993. In vivo binding properties of SH2 domains from GTPase-activating protein and phophatidylinositol 3-kinase. Mol. Cell Biol. 13, 1737-1745.
DOI
|
| 170 |
Cozier, G. E, Bouyoucef, D. and Cullen, P. J. 2003. Engineering the phosphoinositide-binding profile of a class I pleckstrin homology domain. J. Biol. Chem. 278, 39489-39496.
DOI
|
| 171 |
Anand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., Scheppke, L., Huang, M., Shields, D. J., Lindquist, J. N., Lapinski, P. E., King, P. D., Weis, S. M. and Cheresh, D. A. 2010. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 16, 909-914.
DOI
|
| 172 |
Ahmadian, M. R., Hoffmann, U., Goody, R. S. and Wittinghofer, A. 1997. Individual rate constants for the interaction of Ras protein with GTPase-activating protein determined by fluorescence spectroscopy. Biochemistry 36, 4535-4541.
DOI
|
| 173 |
Ahmadian, M. R., Kiel, C., Stege, P. and Scheffzek, K. 2003. Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP. J. Mol. Biol. 329, 699-710.
DOI
|
| 174 |
Allen, M., Chu, S., Brill, S., Stotler, C. and Buckler, A. 1998. Restricted tissue expression pattern of a novel human rasGAP-related gene and its murine ortholog. Gene 218, 17-25.
DOI
|
| 175 |
Arafeh, R., Qutob, N., Emmanuel, R., Keren-Paz, A., Madore, J., Elkahloun, A., Wilmott, J. S., Gartner, J. J., Di Pizio, A., Winograd-Katz, S., Sindiri, S., Rotkopf, R., Dutton-Regester, K., Johansson, P., Pritchard, A. L., Waddell, N., Hill, V. K., Lin, J. C., Hevroni, Y., Rosenberg, S. A., Khan, J., Ben-Dor, S., Niv, M. Y., Ulitsky, I., Mann, G. J., Scolyer, R. A., Hayward, N. K. and Samuels, Y. 2015. Recurrent inactivating RASA2 mutations in melanoma. Nat. Genet. 47, 1408-1410.
DOI
|
| 176 |
Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M. and Collins, F. 1990. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851-859.
DOI
|
| 177 |
Lapinski, P. E., Kwon, S., Lubeck, B. A., Wilkinson, J. E., Srinivasan, R. S., Sevick-Muraca, E. and King, P. D. 2012. RASA1 maintains the lymphatic vasculature in a quiescent functional state in mice. J. Clin. Invest. 122, 733-747.
DOI
|
| 178 |
Fukata, M., Watanabe, T., Noritake, J., Nakagawa, M., Yamaga, M., Kuroda, S., Matsuura, Y., Iwamatsu, A., Perez, F. and Kaibuchi, K. 2002. Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell 109, 873-885.
DOI
|
| 179 |
Gaul, U., Mardon, G. and Rubin, G. M. 1992. A putative Ras GTPase activating protein acts as a negative regulator of signaling by the Sevenless receptor tyrosine kinase. Cell 68, 1007-1009.
DOI
|
| 180 |
Lapinski, P. E., Doosti, A., Salato, V., North, P., Burrows, P. E. and King, P. D. 2018. Somatic second hit mutation of RASA1 in vascular endothelial cells in capillary malformation-arteriovenous malformation. Eur. J. Med. Genet. 61, 11-16.
DOI
|
| 181 |
Lapinski, P. E., Qiao, Y., Chang, C. H. and King, P. D. 2011. A role for p120 RasGAP in thymocyte positive selection and survival of naive T cells. J. Immunol. 187, 151-163.
DOI
|
| 182 |
Largaespada, D. A., Brannan, C. I., Jenkins, N. and Copeland, N. G. 1996. Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat. Genet. 12, 137-143.
DOI
|
| 183 |
Guo, X., Hamilton, P. J., Reish, N. J., Sweatt, J. D., Miller, C. A. and Rumbaugh, G. 2009. Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia. Neuropsychopharmacology 34, 1659-1672.
DOI
|
| 184 |
Ohta, M., Seto, M., Ijichi, H., Miyabayashi, K., Kudo, Y., Mohri, D., Asaoka, Y., Tada, M., Tanaka, Y., Ikenoue, T., Kanai, F., Kawabe, T. and Omata, M. 2009. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Gastroenterology 136, 206-216.
DOI
|
| 185 |
Gioeli, D., Mandell, J. W., Petroni, G. R., Frierson, H. F. Jr. and Weber, M. J. 1999. Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res. 59, 279-284.
|
| 186 |
Gitler, A. D., Kong, Y., Choi, J. K., Zhu, Y., Pear, W. S. and Epstein, J. A. 2004. Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia. Pediatr. Res. 55, 581-584.
DOI
|
| 187 |
Grady, W. M. and Markowitz, S. D. 2002. Genetic and epigenetic alterations in colon cancer. Annu. Rev. Genomics Hum. Genet. 3, 101-128.
DOI
|
| 188 |
Guo, H. F., Tong, J., Hannan, F., Luo, L. and Zhong, Y. 2000. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 403, 895-898.
DOI
|
| 189 |
Stowe, I. B., Mercado, E. L., Stowe, T. R., Bell, E. L., Oses-Prieto, J. A., Hernandez, H., Burlingame, A. L. and McCormick, F. 2012. A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1. Genes Dev. 26, 1421-1426.
DOI
|
| 190 |
Sun, D., Yu, F., Ma, Y., Zhao, R., Chen, X., Zhu, J., Zhang, C. Y., Chen, J. and Zhang, J. 2013. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J. Biol. Chem. 288, 9508-9518.
DOI
|
| 191 |
Liu, D., Yang, C., Bojdani, E., Murugan, A. K. and Xing, M. 2013. Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer. J. Natl. Cancer Inst. 105, 1617-1627.
DOI
|
| 192 |
Laycock-van Spyk, S., Thomas, N., Cooper, D. N. and Upadhyaya, M. 2011. Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Hum. Genomics 5, 623-690.
DOI
|
| 193 |
Le, D. T., Kong, N., Zhu, Y., Lauchle, J. O., Aiyigari, A., Braun, B. S., Wang, E., Kogan, S. C., Le Beau, M. M., Parada, L. and Shannon, K. M. 2004. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 103, 4243-4250.
DOI
|
| 194 |
Legius, E., Marchuk, D. A., Collins, F. S. and Glover, T. W. 1993. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat. Genet. 3, 122-126.
DOI
|
| 195 |
Xie, Y., Yan, J., Cutz, J. C., Rybak, A. P., He, L., Wei, F., Kapoor, A., Schmidt, V. A., Tao, L. and Tang, D. 2012. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis. Biochim. Biophys. Acta. 1822, 875-884.
DOI
|
| 196 |
Xu, G.F., Lin, B., Tanaka, K., Dunn, D., Wood, D., Gesteland, R., White, R., Weiss, R. and Tamanoi, F. 1990. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma. Cell 63, 835-841.
DOI
|
| 197 |
Xu, G. F., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R. and Weiss, R. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599-608.
DOI
|
| 198 |
Cupit, L. D., Schmidt, V. A., Miller, F. and Bahou, W. F. 2004. Distinct PAR/IQGAP expression patterns during murine development: implications for thrombin-associated cytoskeletal reorganization. Mamm. Genome 15, 618-629.
DOI
|
| 199 |
Cozier, G. E., Lockyer, P. J., Reynolds, J. S., Kupzig, S., Bottomley, J. R., Millard, T. H., Banting, G. and Cullen, P. J. 2000. GAP1IP4BP contains a novel group I pleckstrin homology domain that directs constitutive plasma membrane association. J. Biol. Chem. 275, 28261-28268.
|
| 200 |
Cullen, P. J. and Lockyer, P. J. 2002. Integration of calcium and Ras signalling. Nat. Rev. Mol. Cell. Biol. 3, 339-348.
|
| 201 |
D'Angelo, I., Welti, S., Bonneau, F. and Scheffzek, K. 2006. A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep. 7, 174-179.
DOI
|
| 202 |
Davletov, B. A. and Sudhof, T. C. 1993. A single C2 domain from synaptotagmin I is sufficient for high affinity /phospholipid binding. J. Biol. Chem. 268, 26386-26390.
|
| 203 |
Pasmant, E., Sabbagh, A., Hanna, N., Masliah-Planchon, J., Jolly, E., Goussard, P., Ballerini, P., Cartault, F., Barbarot, S., Landman-Parker, J., Soufir, N., Parfait, B., Vidaud, M., Wolkenstein, P., Vidaud, D. and France, R. N. 2009. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J. Med. Genet. 46, 425-430.
DOI
|
| 204 |
Osaki. M., Oshimura, M. and Ito, H. 2004. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9, 667-676.
DOI
|
| 205 |
Ouyang, X., Jessen, W. J., Al-Ahmadie, H., Serio, A. M., Lin, Y., Shih, W. J., Reuter, V. E., Scardino, P. T., Shen, M. M., Aronow, B. J., Vickers, A. J., Gerald, W. L. and Abate-Shen, C. 2008. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res. 68, 2132-2144.
DOI
|
| 206 |
Pamonsinlapatham, P., Hadj-Slimane, R., Lepelletier, Y., Allain, B., Toccafondi, M., Garbay, C. and Raynaud, F. 2009. p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling. Biochimie 91, 320-328.
DOI
|
| 207 |
Pena, V., Hothorn, M., Eberth, A., Kaschau, N., Parret, A., Gremer, L., Bonneau, F., Ahmadian, M. R. and Scheffzek, K. 2008. The C2 domain of SynGAP is essential for stimulation of the Rap GTPase reaction. EMBO Rep. 9, 350-355.
DOI
|
| 208 |
Pereira-Leal, J. B. and Seabra, M. C. 2001. Evolution of the Rab family of small GTP-binding proteins. J. Mol. Biol. 313, 889-901.
DOI
|
| 209 |
Sung, H., Kanchi, K. L., Wang, X., Hill, K. S., Messina, J. L., Lee, J. H., Kim, Y., Dees, N. D., Ding, L., Teer, J. K., Yang, S., Sarnaik, A. A., Sondak, V. K., Mule, J. J., Wilson, R. K., Weber, J. S. and Kim, M. 2016. Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation. Oncotarget 7, 23885-23896.
|
| 210 |
Sun, L., Yao, Y., Shang, Z., Zhan, S., Shi, W., Pan, G., Zhu, X. and He, S. 2018. DAB2IP downregulation enhances the proliferation and metastasis of human gastric cancer cells by depressing the ERK1/2 pathway. Gasroenterol. Res. Pract. 2018, 2968252.
|
| 211 |
Tanaka, K., Nakafumi, M., Satoh, T., Marshall, M. S., Gibbs, J. B., Matsumoto, K. and Toh-e, A. 1990. S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell 9, 803-807.
|
| 212 |
Thomas, E. K., Cancelas, J. A., Chae, H. D., Cox, A. D., Keller, P. J., Perrotti, D., Neviani, P., Drucker, B. J., Setchell, K. D. R., Zheng, Y., Harris, C. E. and Williams, D. A. 2007. Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. Cancer Cell 12, 467-478.
DOI
|
| 213 |
Trahey, M., Wong, G., Halenbeck, R., Rubinfeld, B., Martin, G. A. Lander, M., Long, C. M., Crosier, W. J., Watt, K., Koths, K. MaCormick, F. 1988. Molecular cloning of two types of GAP complementary DNA from human placenta. Science 242, 1697-1700.
DOI
|
| 214 |
Yang, Y., Zhao, W., Xu, Q. W., Wang, X. S., Zhang, Y. and Zhang, J. 2014. IQGAP3 promotes EGFR-ERK signaling and the growth and metastasis of lung cancer cells. PLoS One 9, e97578.
DOI
|
| 215 |
Xu. X., Tan, X., Tampe, B., Nyamsuren, G., Liu, X., Maier, L. S., Sossalla, S., Kalluri, R., Zeisberg, M., Hasenfuss, G. and Zeisberg, E. M. 2015. Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis. Cardiovasc. Res. 105, 279-291.
DOI
|
| 216 |
Yamamoto, T., Matsui, T., Nakafuku, M., Iwamatsu, A. and Kaibuchi, K. 1995. A novel GTPase-activating protein for R-Ras. J. Biol. Chem. 270, 30557-30561.
DOI
|
| 217 |
Yang, F. C., Kapur, R., King, A. J., Tao, W., Kim, C., Borneo, J., Breese, R., Marshall, M., Dinauer, M. C. and Williams, D. A. 2000. Rac2 stimulates Akt activation affecting BAD/ Bcl-XL expression while mediating survival and actin function in primary mast cells. Immunity 12, 557-568.
DOI
|
| 218 |
Yano, M., Toyooka, S., Tsukuda, K., Dote, H., Ouchida, M., Hanabata, T., Aoe, M., Date, H., Gazdar, A. F. and Shimizu, N. 2005. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int. J. Cancer 113, 59-66.
DOI
|
| 219 |
De Schepper, S., Maertens, O., Callens, T., Naeyaert, J. M., Lambert, J. and Messiaen, L. 2008. Somatic mutation analysis in NF1 cafe au lait spots reveals two NF1 hits in the melanocytes. J. Invest. Dermatol. 128, 1050-1053.
DOI
|
| 220 |
Davoli, T. 1., Xu, A. W., Mengwasser, K. E., Sack, L. M., Yoon, J. C., Park, P. J. and Elledge, S. J. 2013. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948-962.
DOI
|
| 221 |
de Wijn, R. S., Oduber, C. E., Breugem, C. C., Alders, M., Hennekam, R. C. and van der Horst, C. M. 2012. Phenotypic variability in a family with capillary malformations caused by a mutation in the RASA1 gene. Eur. J. Med Genet. 55, 191-195.
DOI
|
| 222 |
Bernard, A. 2003. GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochim. Biophysi. Acta. 1603, 47-82.
|
| 223 |
Baralle, M. and Baralle, D. 2012. Splicing mechanisms and mutations in the NF1 gene. In: Upadhyaya, M. and Cooper, D. (eds) Neurofibromatosis tyie 1. Springer, Berlin, Heidelberg. pp 135-150.
|
| 224 |
Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S. and Downward, J. 1992. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356, 713-715.
DOI
|
| 225 |
Bechtel, W., McGoohan, S., Zeisberg, E. M., Muller, G. A., Kalbacher, H., Salant, D. J., Muller, C. A., Kalluri, R. and Zeisberg, M. 2010. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16, 544-550.
DOI
|
| 226 |
Blanc, L., Ciciotte, S. L., Gwynn, B., Hildick-Smith, G. J., Pierce, E. L., Soltis, K. A., Cooney, J. D., Paw, B. H. and Peters, L. L. 2012. Critical function for the Ras-GTPase activating protein RASA3 in vertebrate erythropoiesis and megakaryopoiesis. Proc. Natl. Acad. Sci. USA. 109, 12099-12104.
DOI
|
| 227 |
Bollag, G. Clapp, D. W., Shih, S., Adler, F., Zhang, Y. Y., Thompson, P., Lange, B. J., Freedman, M. H., McCormick, F., Jacks, T. and Shannon, K. 1996. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat. Genet. 12, 144-148.
DOI
|
| 228 |
Boon, L. M., Mulliken, J. B. and Vikkula, M. 2005. RASA1: variable phenotype with capillary and arteriovenous malformations. Curr. Opin. Genet. Dev. 15, 265-269.
DOI
|
| 229 |
Liu, Q., Walker, S. A., Gao, D., Taylor, J. A., Dai, Y. F., Arkell, R. S., Bootman, M. D., Roderick, H. L., Cullen, P. J. and Lockyer, P. J. 2005. CAPRI and RASAL impose different modes of information processing on Ras due to contrasting temporal filtering of . J. Cell Biol. 170, 183-190.
DOI
|
webmaster
